Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era

• Glavni autori: Sara Madureira Gomes (Autor), Rita Pissarra Teixeira (Autor), Gustavo Rocha (Autor), Paulo Soares (Autor), Hercilia Guimaraes (Autor), Paulo Santos (Autor), Joana Jardim (Autor), João Luís Barreira (Autor), Helena Pinto (Autor)
• Format: Knjiga
• Izdano: Thieme Medical Publishers, Inc., 2021-04-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

The atypical hemolytic uremic syndrome (aHUS) in the newborn is a rare disease, with high morbidity. Eculizumab, considered a first-line drug in older children, is not approved in neonates and in children weighing less than 5 kg. We present a 5-day-old female newborn, born at 36 weeks' twin ges...